To include your compound in the COVID-19 Resource Center, submit it here.

Imprime PGG: Phase III started

Biothera began an open-label, international Phase III trial to compare 4 mg/kg Imprime PGG weekly

Read the full 152 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE